Athira Pharma Inc share price logo

Athira Pharma Inc Share Price

NASDAQ: ATHA

Small Cap

$0.39

+0.01

(+1.32%)

as on

Athira Pharma Inc Stock Performance

as on September 4, 2025 at 1:29 am IST

  • Day's Low

    $0.38
    $0.39
    downward going graph

    2.56%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.22
    $3.03
    downward going graph

    43.71%

    Downside

    676.92%

    Upside

    downward going graph

Athira Pharma Inc share price movements today

Previous Close
$0.39
Open
$0.39
Volume
242.1K
Day's Low - High
$0.38 - $0.39
52 Week Low - High
$0.22 - $3.03

Athira Pharma Inc Historical Returns

1 Month Return
+ 4.97 %
3 Month Return
+ 28.55 %
1 Year Return
-86.27 %
3 Year Return
-88.08 %
5 Year Return
0 %

Athira Pharma Inc Stock Fundamentals & Key Indicators

Check Athira Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.3M

EPS (TTM)

-0.62

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-56.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

138667400.00%

Athira Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Athira Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$15.3MNANA0.00%
BUY$58.6B256.67%-505.15-12.96%
NA$35.6BNANA-3.89%
BUY$102.8B46.22%28.4831.86%
BUY$61.5B0.57%14.6431.37%

Stock Returns calculator for Athira Pharma Inc Stock including INR - Dollar returns

The Athira Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Athira Pharma Inc investment value today

Current value as on today

₹18,700

Returns

₹81,300

(-81.3%)

Returns from Athira Pharma Inc Stock

₹86,219 (-86.22%)

Dollar Returns*

₹4,919 (+4.92%)

Analyst Recommendation on Athira Pharma Inc Stock

Based on 12 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Athira Pharma Inc. Average target price of $0.5

Athira Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Athira Pharma Inc.

What analysts predicted

22%UPSIDE

Target Price

$0.5

Current Price

$0.39

Analyzed by

12 Analysts

Target

$0.50

Athira Pharma Inc target price $0.5, a slight upside of 22% compared to current price of $0.39. According to 12 analysts rating.

Athira Pharma Inc Stock's Interest Amongst Investors

Search interest for Athira Pharma Inc Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

Athira Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
1
-
-
-
0
-
-
Gross Profit
0
0
0
1
0
0
0
0
0
0
Operating Income
-29
-31
-35
-29
-27
-28
-29
-15
-9
-7
EBITDA
-29
-31
-34
-30
-27
-27
-25
-15
-8
-6
Interest Expense
1
-
-
1
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-29
-32
-27
-26
-26
-28
-15
-9
-6
Income Tax Expense
-1
0
0
2
0
-
-
-
-
-
Net Income
-25
-29
-32
-27
-26
-26
-28
-15
-9
-6
Net Profit Margin
0.00%
0.00%
0.00%
-1647.64%
0.00%
0.00%
0.00%
-1549.90%
0.00%
0.00%

Athira Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-2
0
-1
0
0
Operating Income
-5
-5
-19
-64
-104
-127
-100
EBITDA
0
-4
-19
-54
-94
-116
-95
Interest Expense
0
0
0
0
24
-
-
Depreciation
-
-
0
0
0
0
0
Income Before Tax
-5
-5
-19
-54
-95
-117
-96
Income Tax Expense
0
0
-1
0
-8
-1
-
Net Income
-5
-5
-19
-54
-95
-117
-96
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Athira Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-29
-32
-27
-26
-26
-28
-15
-9
-6
Operating Cash Flow
-24
-23
-26
-25
-22
-23
-26
-14
-6
Investing Cash Flow
32
20
6
13
26
18
-2
-7
0
Financing Cash Flow
0
-
0
-
0
0
0
-
0
Change in Cash
8
-3
-19
-12
4
-4
-28
-22
-6

Athira Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-5
-19
-54
-95
-117
-96
Operating Cash Flow
-3
-24
-43
-72
-100
-97
Investing Cash Flow
1
-210
-4
57
95
54
Financing Cash Flow
0
292
97
0
0
0
Change in Cash
-1
58
49
-14
-5
-42

Global Institutional Holdings in Athira Pharma Inc

Funds
Holdings
Perceptive Advisors LLC
13.84%
BML Capital Management LLC
8.2%
Vanguard Group Inc
3.94%
Simplify Asset Management Inc.
3.82%
Propel Bio Management LLC
3.82%

Insights on Athira Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 99.5% return, outperforming this stock by 187.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 76.9% return, outperforming this stock by 163.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, ATHA stock has moved down by -86.4%

About Athira Pharma Inc

m3 biotechnology is an innovative therapeutics company that has a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative diseases. the lead compound modifies growth-factor systems, where the activation is expected to stop disease progression and even restore lost function. the company’s research has been funded by the alzheimer’s drug discovery foundation, washington’s life sciences discovery fund, w fund, wrf capital, dolby family ventures and other private investors. where current and emerging therapies are focused primarily on disease symptoms and improving the quality of life of patients suffering from disease, m3 differentiates itself from the competition by addressing the neurodegenerative process, providing a cost-effective solution and feasible delivery mechanism. our strategy is to leverage our patented and proprietary technologies to develop small molecule modulators with a primary focus on altering the course of alzheimer
OrganisationAthira Pharma Inc
Headquarters18706 North Creek Parkway, Bothell, WA, United States, 98011
IndustryCommercial Services
CEODr. Mark J. Litton M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Athira Pharma Inc

Name

Title

Dr. Mark J. Litton M.B.A., Ph.D.

President, CEO & Director

Dr. Kevin Church Ph.D.

Chief Scientific Officer

Mr. Mark F. Worthington J.D.

General Counsel, Chief Compliance Officer & Corporate Secretary

Mr. Robert Renninger

Senior VP of Finance & Accounting, Principal Financial Officer and Principal Accounting Officer

Ms. Julie Rathbun

Head of Investor Relations

Dr. Javier San Martin M.D.

Chief Medical Officer

FAQs

What is Athira Pharma Inc share price today?

Athira Pharma Inc share price today is $0.39 as on at the close of the market. Athira Pharma Inc share today touched a day high of $0.39 and a low of $0.38.

What is the 52 week high and 52 week low for Athira Pharma Inc share?

Athira Pharma Inc share touched a 52 week high of $3.03 on and a 52 week low of $0.22 on . Athira Pharma Inc stock price today i.e. is closed at $0.39,which is 87.13% down from its 52 week high and 77.64% up from its 52 week low.

What is Athira Pharma Inc's market capitalisation today?

Athira Pharma Inc market capitalisation is $0.00T as on .

How to invest in Athira Pharma Inc Stock (ATHA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Athira Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Athira Pharma Inc Shares that will get you 3.8462 shares as per Athira Pharma Inc share price of $0.39 per share as on September 4, 2025 at 1:29 am IST.

What is the minimum amount required to buy Athira Pharma Inc Stock (ATHA) from India?

Indian investors can start investing in Athira Pharma Inc (ATHA) shares with as little as ₹88.035 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.35 in Athira Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Athira Pharma Inc share’s latest price of $0.39 as on September 4, 2025 at 1:29 am IST, you will get 25.6410 shares of Athira Pharma Inc. Learn more about fractional shares .